The budget impact of tegaserod on a managed care organization formulary

被引：0
|
作者：
Bloom, MA
Barghout, V
Kahler, KH
Bentkover, JD
Kurth, H
Gralnek, IM
Spiegel, B
机构：
[1] Innovat Hlth Solut, Brookline, MA USA
[2] Novartis Pharmaceut Corp, E Hanover, NJ USA
[3] Univ Calif Los Angeles, VA Greater Los Angeles Healthcare Syst, CURE Digest Dis Res Ctr, David Geffen Sch Med, Los Angeles, CA USA
[4] VA Greater Los Angeles Healthcare Syst, Dept Gastroenterol & Hepatol, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62991-9
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：370 / 370
页数：1
相关论文
共 50 条
  • [31] Influenza immunization in a managed care organization
    Baker, AM
    McCarthy, B
    Gurley, VF
    Yood, MU
    JOURNAL OF GENERAL INTERNAL MEDICINE, 1998, 13 (07) : 469 - 475
  • [32] The burden of rhinitis in a managed care organization
    Schatz, Michael
    Zeiger, Robert S.
    Chen, Wansu
    Yang, Su-Jau
    Corrao, Marlo A.
    Quinn, Virginia P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 101 (03) : 240 - 247
  • [33] Influenza immunization in a managed care organization
    Ann M. Baker
    Bruce McCarthy
    Virginia F. Gurley
    Marianne Ulcickas Yood
    Journal of General Internal Medicine, 1998, 13 : 469 - 475
  • [34] Maternity experiences in a managed care organization
    Gazmararian, JA
    Koplan, JP
    Cogswell, ME
    Bailey, CM
    Davis, NA
    Cutler, CM
    HEALTH AFFAIRS, 1997, 16 (03) : 198 - 208
  • [35] IMPACT OF A FORMULARY ON PERSONAL CARE HOMES IN MANITOBA
    YAKABOWICH, MR
    KEELEY, G
    MONTGOMERY, PR
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1994, 150 (10) : 1601 - 1607
  • [36] ANALYSIS OF GENERIC SIMVASTATIN AND ATORVASTATIN VERSUS BRANDED ROSUVASTATIN IN HYPERLIPIDEMIA PATIENTS: A BUDGET IMPACT MODEL FROM A MANAGED CARE ORGANIZATION PERSPECTIVE IN THE UNITED STATES
    Ruff, L.
    Montouchet, C.
    Balu, S.
    VALUE IN HEALTH, 2012, 15 (04) : A117 - A117
  • [37] Effectiveness of tegaserod therapy on GI-related resource utilization in a managed care population
    Stephenson, JJ
    Barghout, V
    Kahler, KH
    Fernandes, J
    Beaulieu, JF
    Joo, S
    Boccuzzi, SJ
    AMERICAN JOURNAL OF MANAGED CARE, 2005, 11 (01): : S35 - S42
  • [38] BUDGET IMPACT OF INCREASED UTILIZATION OF PALONOSETRON FOR THE CONTROL OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN MANAGED CARE
    Knoth, R. L.
    Ortendahl, J. D.
    Copher, R.
    VALUE IN HEALTH, 2017, 20 (05) : A98 - A98
  • [39] The academy of managed care pharmacy Format for Formulary Submissions:: An evolving standard -: A foundation for Managed Care Pharmacy task force report
    Fry, RN
    Avey, SG
    Sullivan, SD
    VALUE IN HEALTH, 2003, 6 (05) : 505 - 521
  • [40] Academy of Managed Care Pharmacy 1997 Educational Conference - Update on bacterial resistance, developing a glaucoma formulary, closing a formulary ...
    不详
    FORMULARY, 1998, 33 (02) : 147 - +
12345